ATIS is on the move! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move!

ATIS 0.1000

-47.4%

Apr 14 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David S. who wrote (1156)	11/13/1997 7:17:00 PM
From: Harry D. Kramer	of 2205

David, If you take out the net present value of Dermagraft (ulcers) you end up with about $200 million-300 million for ATIS. Taking the frustration into account that would occur if something happens to Dermagraft, you probably would have to subtract another 50% for a reasonable stockmarket valuation. Well $150 million, here we are. Just playing with numbers, not that I think it is something that will really happen. But if you are right with the healing quality, sales projections could definitely be on the high side. It is also another argument for not underestimating competition like Regranex. Have a nice day, Harry

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next